TABLE 1.
Demographic and clinical characteristics of study participants
| Characteristic | No. (%) or median [IQR] |
P (for difference) | |
|---|---|---|---|
| S. haematobium infected (n = 11) | S. haematobium uninfected (n = 22) | ||
| Mean age in yrs | 25 [21–38] | 29 [25–33] | 0.42 |
| Female gender | 6 (54.6) | 14 (63.6) | 0.61 |
| Currently breastfeeding | 3/6 (50.0) | 5/14 (38.5) | 0.64 |
| Marital status | |||
| Married | 9 (81.8) | 18 (81.8) | |
| Single/divorced/widowed | 2 (18.2) | 4 (18.2) | 1.0 |
| Yrs of school completed | 7 [2–7] | 7 [0–7] | 0.96 |
| History of receiving treatment for schistosome infection | 4 (36.4) | 6 (27.3) | 0.70 |
| C. trachomatis PCR positive (genital tract/urine) | 1 (9.1) | 2 (9.1) | 1.0 |
| N. gonorrhoeae PCR positive (genital tract/urine) | 0 | 1 (4.5) | 1.0 |
| S. haematobium ova/10 ml of urine | 4 [2–13] | 0 | <0.001 |
| Serum schistosome circulating anodic antigen (pg/ml)a | 919 [327–50,000] | 2 [0–6] | <0.001 |
a
The schistosome-infected group included individuals who had serum antigen levels of ≥40 pg/ml, and the uninfected group included those with a CAA of <25 pg/ml.